PARP1 and prostate carcinoma: We compared the expression PARP1 and FOLH1 across a range of prostate and prostate cancer cells Fig. 2A. 22Rv1 expresses both targets; and we then evaluated the specificity of uptake of rucaparib in these cells by fluorescence microscopy.